Upgrade to SI Premium - Free Trial

Wolfe Research Starts Zymeworks (ZYME) at Outperform

September 17, 2026 5:03 AM

Wolfe Research analyst Kalpit Patel initiates coverage on Zymeworks (NASDAQ: ZYME) with a Outperform rating.


For an analyst ratings summary and ratings history on Zymeworks click here. For more ratings news on Zymeworks click here.


Shares of Zymeworks closed at $26.24 yesterday.

Categories

New Coverage